ArticleCureus2025
Recurrent Guillain-Barré Syndrome: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy, which is generally considered to be monophasic, but recurrences can occur in rare cases. A 66-year-old lady presented with complaints of bilateral lower limb weakness progressing to bilateral upper limb involvement over 20 days. The examination revealed lower limb weakness and absent deep tendon reflexes. She had a history of two similar episodes, diagnosed as GBS, with nerve conduction studies showing demyelinating polyneuropathy and elevated protein in the cerebrospinal fluid. The current episode revealed identical findings, along with positive anti-ganglioside antibodies. She was treated with intravenous immunoglobulin (IVIG) and physiotherapy, resulting in partial recovery at discharge three weeks after symptom onset and near-complete resolution at the three-month follow-up. This case enriches the understanding of recurrent GBS and the importance of differentiating it from treatment-related fluctuation and or chronic inflammatory demyelinating polyneuropathy with acute onset. It further sheds light upon diagnostic interventions and recent advances in management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.